Loading clinical trials...
Loading clinical trials...
Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping: an Umbrella Phase II Exploratory Clinical Study
Conditions
Interventions
Trastuzumab
Adebrelimab
+8 more
Start Date
May 1, 2025
Primary Completion Date
August 1, 2029
Completion Date
November 1, 2029
Last Updated
March 18, 2025
NCT06921928
NCT06257264
NCT07537348
NCT06427941
NCT06253871
NCT06464978
Lead Sponsor
China Medical University, China
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions